JWK006
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JWK006, covering 2024-03-08 to 2024-03-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1) [Phase 1, Phase 2]